KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Notes Payables (2017 - 2018)

Historic Notes Payables for Astrana Health (ASTH) over the last 5 years, with Q4 2018 value amounting to $40257.0.

  • Astrana Health's Notes Payables fell 9211.25% to $40257.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $40257.0, marking a year-over-year decrease of 9211.25%. This contributed to the annual value of $40257.0 for FY2018, which is 9211.25% down from last year.
  • Astrana Health's Notes Payables amounted to $40257.0 in Q4 2018, which was down 9211.25% from $159906.0 recorded in Q3 2018.
  • Over the past 5 years, Astrana Health's Notes Payables peaked at $4.9 million during Q3 2017, and registered a low of $40257.0 during Q4 2018.
  • Over the past 3 years, Astrana Health's median Notes Payables value was $1.1 million (recorded in 2015), while the average stood at $1.9 million.
  • Over the last 5 years, Astrana Health's Notes Payables had its largest YoY gain of 9182.47% in 2018, and its largest YoY loss of 9676.06% in 2018.
  • Astrana Health's Notes Payables (Quarter) stood at $1.1 million in 2015, then tumbled by 53.34% to $510391.0 in 2017, then plummeted by 92.11% to $40257.0 in 2018.
  • Its last three reported values are $40257.0 in Q4 2018, $159906.0 for Q3 2018, and $278017.0 during Q2 2018.